With more than 25 years’ global experience in product development and commercial leadership across therapeutic areas within the biotech and pharmaceutical industry, Frank joined as CEO of FORMA Therapeutics in March of 2019. Frank previously spent 13 years at Genentech in leadership positions of increasing scope, most recently as Senior Vice President, Global Product Strategy, and Therapeutic Area Head for the Immunology, Ophthalmology and Infectious Diseases division. Before joining Genentech, Frank served in various roles roles at Novartis, Janssen, and Eli Lilly. Frank received a BA in chemical engineering from Vanderbilt University and an MBA in marketing and finance from the Wharton Graduate School of Business.